-
15m 45sPart 2 | Session 4 Day 4 Wrap-Up: OCCUPI, REC-CAGEFREE I, AEGIS-II & More
-
20m 58sPart 3 | Session 1 AβYSS: Beta Blocker Interruption After Uncomplicated MI
-
20m 14sPart 3 | Session 2 RHEIA: TAVR vs SAVR in Women with Severe AS
-
8m 47sPart 3 | Session 3 OCEANIC-AF: Asundexian Vs Apixaban in Atrial Fibrillation
-
9m 29sPart 3 | Session 4 SWEDEGRAFT: No-touch Vein Graft in CABG
-
17m 28sPart 3 | Session 5 FINEARTS-HF: Finerenone HFmEF & HFpEF
-
6m 8s
-
5m 29sPart 4 | Session 2 MATTERHORN: M-TEER vs Surgery in Heart Failure
-
5m 46sPart 4 | Session 3 MRAs in Heart Failure
-
4m 24sPart 4 | Session 4 FINE-HEART: Finerenone in HF & CKD
-
8m 18sPart 4 | Session 5 STEEER-AF: Stroke Prevention & Rhythm Control Therapy
-
3m 52sPart 4 | Session 6 NOTION-3: FFR Guided PCI in TAVI
-
6m 48sPart 4 | Session 7 EPIC-CAD: Edoxaban vs Dual Antiplatelet Therapy in AF & CAD
-
8m 17sPart 4 | Session 8 SENIOR RITA: Invasive Vs Conservative Strategy for Older Patients with MI
-
3m 51sPart 4 | Session 9 EARTH-STEMI: Complete Vs Culprit-Only Revascularization in Older Patients
-
4m 17sPart 4 | Session 10 SCOFF: Fasting vs. Non-Fasting: Impact on Cardiac Catheterization Outcomes
-
4m 17sPart 4 | Session 11 GUARD-AF: Atrial Fibrillation Screening to Reduce Stroke in Elderly Individuals
-
2m 31s
-
7m 9sPart 4 | Session 13 POPular PAUSE TAVI: Continuation or interruption of OAC During TAVI
-
4m 54sPart 5 | Session 1 3 Trials That Will Change My Practice With Dr Muthiah Vaduganathan
-
13m 47sPart 5 | Session 2 3 Trials That Will Change My Practice With Dr Michelle Kittleson
-
6m 55sPart 6 | Session 1 New Guidelines for the Management of Atrial Fibrillation
-
6m 13sPart 6 | Session 2 New Guidelines for the Management of Aortic Diseases
-
47m 31sPart 1 | Session 1 ESC Congress 2024 Hot Line Wrap Up
-
27m 27sPart 1 | Session 2 ESC Congress 2024 Hot Line Preview
-
17m 25sPart 2 | Session 1 ESC Day 1 Wrap Up: New Guidelines, HELIOS-B, ABYSS & STOP-or-NOT
-
23m 2sPart 2 | Session 2 ESC Day 2 Wrap-Up: NOTION-3, RESHAPE-HF2, TRI.Fr & More
ESC Congress 24 – Join Dr Mirvat Alasnag and Dr Khaled Al-Shaibi (The King Fahd Armed Forces Hospital, SA) for an insightful series of wrap-ups from the ESC Congress 2024 in London.
Trials covered in detail include:
FINEARTS-HF
MRAs in Heart Failure
SENIOR RITA
EARTH-STEMI
SCOFF
AVATAR
Watch the Day 1 and Day 2 ESC 24 wrap-ups from Dr Alasnag and Dr Al-Shaibi here.
Recorded on-site at the ESC Congress 2024, London.
Editors: Mirjam Boros and Jordan Rance.
Video Specialists: Dan Brent, Tom Green, Mike Knight, Oliver Miles, David Ben-Harosh.
Support: This is an independent discussion produced by Radcliffe Cardiology.
What's hot at the ESC Congress 2024?
Stay ahead of the curve with our faculty-led coverage of the European Society of Cardiology Congress in London. From groundbreaking trials to expert insights, we've got you covered.
- Watch our View From the Thoraxcenter series for practice-focused reviews of the most anticipated trials from interventional experts, Prof Nicolas Van Mieghem and Dr Joost Daemen.
- For a deeper dive into key hot line clinical trial data and its applicability, host, Dr Harriette Van Spall meets with principal investigators in her Late-Breaker Discussion series.
- View a condensed summary of the crucial takeaways from each day in our Wrap-Up series led by Dr Mirvat Alasnag.
- Our short, bite-sized Expert Interviews with select faculty will focus on data, take-home messages for practice and the future of their field.
Get ready for a deep dive into the latest cardiology research. Our coverage of the ESC Congress is coming soon.
More from this programme
Part 1
View From the Thoraxcenter: What's Hot at ESC 24?
Part 2
Daily Wrap Ups with Dr Alasnag and Dr Al-Shaibi
Part 3
Hot-line Discussions with Dr Harriette Van Spall
Part 4
Expert Interviews
Part 5
Highlights
Part 6
Guidelines
Faculty Biographies
Mirvat Alasnag
Director of Catheterization Laboratory
Dr. Mirvat Alasnag is a consultant interventional cardiologist based in Jeddah, Saudi Arabia. She is Director of the Catheterization Laboratory at King Fahad Armed Forces Hospital, where she has played a central role in the development of contemporary interventional cardiology services. Dr. Alasnag is recognised as the first female interventional cardiologist in the Gulf region and has been a prominent advocate for women in cardiology, representing female physicians on multiple national and international committees.
Academic History
Dr. Alasnag completed her training in Clinical Cardiology at Loma Linda University Medical Center in Loma Linda, California. She subsequently undertook advanced training in Interventional Cardiology at Harper University Hospital, Detroit Medical Center, in Detroit, Michigan. Her training combined high-volume clinical practice with exposure to complex coronary interventions, forming the foundation for her subsequent leadership…
Khaled Al-Shaibi
Director Cardiac Center
Dr Khaled Al-Shaibi is the Director at King Fahd Armed Forces Hospital. He earned his Doctor of Medicine degree from King Abdulaziz University in Jeddah, Saudi Arabia, in 1986.
Dr Al-Shaibi completed his residency in Internal Medicine at the University of Alabama at Birmingham (UAB) Medical Center from 1988 to 1991. Furthering his specialisation, Dr Al-Shaibi completed a Cardiology Fellowship at UAB Medical Center from 1991 to 1994, leading to his ABIM certification in Cardiovascular Disease in 1995. He then pursued advanced training through an Interventional Cardiology Fellowship at UAB Medical Center from 1994 to 1996, earning ABIM certification in Interventional Cardiology in 1997.
Dr Al-Shaibi's outstanding contributions to interventional cardiology in Saudi Arabia have been widely recognised. In 2016, he received the Lifetime Achievement Award from the Saudi Arabian Coronary Interventional Society. His dedication to the field of cardiology was further honoured by…
Comments